Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Short amplicon reverse transcription-polymerase chain reaction detects aberrant splicing in genes with low expression in blood missed by ribonucleic acid sequencing analysis for clinical diagnosis

HA. Wai, M. Constable, C. Drewes, IC. Davies, E. Svobodova, E. Dempsey, A. Saggar, T. Homfray, S. Mansour, S. Douzgou, K. Barr, C. Mercer, D. Hunt, AGL. Douglas, D. Baralle

. 2022 ; 43 (7) : 963-970. [pub] 20220427

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc22017896

Use of blood RNA sequencing (RNA-seq) as a splicing analysis tool for clinical interpretation of variants of uncertain significance (VUSs) found via whole-genome and exome sequencing can be difficult for genes that have low expression in the blood due to insufficient read count coverage aligned to specific genes of interest. Here, we present a short amplicon reverse transcription-polymerase chain reaction(RT-PCR) for the detection of genes with low blood expression. Short amplicon RT-PCR, is designed to span three exons where an exon harboring a variant is flanked by one upstream and one downstream exon. We tested short amplicon RT-PCRs for genes that have median transcripts per million (TPM) values less than one according to the genotype-tissue expression database. Median TPM values of genes analyzed in this study are SYN1 = 0.8549, COL1A1 = 0.6275, TCF4 = 0.4009, DSP = .2894, TTN = 0.2851, COL5A2 = 0.1036, TERT = 0.04452, NTRK2 = 0.0344, ABCA4 = 0.00744, PRPH = 0, and WT1 = 0. All these genes show insufficient exon-spanning read coverage in our RNA-seq data to allow splicing analysis. We successfully detected all genes tested except PRPH and WT1. Aberrant splicing was detected in SYN1, TCF4, NTRK2, TTN, and TERT VUSs. Therefore, our results show short amplicon RT-PCR is a useful alternative for the analysis of splicing events in genes with low TPM in blood RNA for clinical diagnostics.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017896
003      
CZ-PrNML
005      
20220929144516.0
007      
ta
008      
220720s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/humu.24378 $2 doi
035    __
$a (PubMed)35476365
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wai, Htoo A $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK $1 https://orcid.org/0000000235606980
245    10
$a Short amplicon reverse transcription-polymerase chain reaction detects aberrant splicing in genes with low expression in blood missed by ribonucleic acid sequencing analysis for clinical diagnosis / $c HA. Wai, M. Constable, C. Drewes, IC. Davies, E. Svobodova, E. Dempsey, A. Saggar, T. Homfray, S. Mansour, S. Douzgou, K. Barr, C. Mercer, D. Hunt, AGL. Douglas, D. Baralle
520    9_
$a Use of blood RNA sequencing (RNA-seq) as a splicing analysis tool for clinical interpretation of variants of uncertain significance (VUSs) found via whole-genome and exome sequencing can be difficult for genes that have low expression in the blood due to insufficient read count coverage aligned to specific genes of interest. Here, we present a short amplicon reverse transcription-polymerase chain reaction(RT-PCR) for the detection of genes with low blood expression. Short amplicon RT-PCR, is designed to span three exons where an exon harboring a variant is flanked by one upstream and one downstream exon. We tested short amplicon RT-PCRs for genes that have median transcripts per million (TPM) values less than one according to the genotype-tissue expression database. Median TPM values of genes analyzed in this study are SYN1 = 0.8549, COL1A1 = 0.6275, TCF4 = 0.4009, DSP = .2894, TTN = 0.2851, COL5A2 = 0.1036, TERT = 0.04452, NTRK2 = 0.0344, ABCA4 = 0.00744, PRPH = 0, and WT1 = 0. All these genes show insufficient exon-spanning read coverage in our RNA-seq data to allow splicing analysis. We successfully detected all genes tested except PRPH and WT1. Aberrant splicing was detected in SYN1, TCF4, NTRK2, TTN, and TERT VUSs. Therefore, our results show short amplicon RT-PCR is a useful alternative for the analysis of splicing events in genes with low TPM in blood RNA for clinical diagnostics.
650    _2
$a ABC transportéry $x genetika $7 D018528
650    12
$a alternativní sestřih $7 D017398
650    _2
$a lidé $7 D006801
650    12
$a RNA $x genetika $7 D012313
650    _2
$a sestřih RNA $x genetika $7 D012326
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a reverzní transkripce $7 D048348
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Constable, Matthew $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK
700    1_
$a Drewes, Cosima $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK
700    1_
$a Davies, Ian C $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK
700    1_
$a Táborská, Eliška $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic $7 ola20211133478
700    1_
$a Dempsey, Esther $u Department of Clinical Genetics, St George's University of London, London, UK
700    1_
$a Saggar, Anand $u Department of Clinical Genetics, St George's University of London, London, UK
700    1_
$a Homfray, Tessa $u Department of Clinical Genetics, St George's University of London, London, UK
700    1_
$a Mansour, Sahar $u Department of Clinical Genetics, St George's University of London, London, UK
700    1_
$a Douzgou, Sofia $u Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Health Innovation Manchester, Manchester, UK $u Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, UK
700    1_
$a Barr, Kate $u Bristol Regional Clinical Genetics Service, St Michael's Hospital, Bristol, UK
700    1_
$a Mercer, Catherine $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
700    1_
$a Hunt, David $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK $u Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK
700    1_
$a Douglas, Andrew G L $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK $u Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK
700    1_
$a Baralle, Diana $u Human Development and Health, Faculty of Medicine, Southampton General Hospital, University of Southampton, Southampton, UK $u Wessex Clinical Genetics Service, University Hospital Southampton NHS Foundation Trust, Southampton, UK $1 https://orcid.org/0000000332174833
773    0_
$w MED00002078 $t Human mutation $x 1098-1004 $g Roč. 43, č. 7 (2022), s. 963-970
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35476365 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220929144510 $b ABA008
999    __
$a ok $b bmc $g 1821815 $s 1169139
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 43 $c 7 $d 963-970 $e 20220427 $i 1098-1004 $m Human mutation $n Hum Mutat $x MED00002078
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options